Intracellular heat shock protein-70 negatively regulates TLR4 signaling in the newborn intestinal epithelium

J Immunol. 2012 May 1;188(9):4543-57. doi: 10.4049/jimmunol.1103114. Epub 2012 Mar 28.

Abstract

Necrotizing enterocolitis (NEC) is the leading cause of gastrointestinal-related mortality in premature infants, and it develops under conditions of exaggerated TLR4 signaling in the newborn intestinal epithelium. Because NEC does not develop spontaneously, despite the presence of seemingly tonic stimulation of intestinal TLR4, we hypothesized that mechanisms must exist to constrain TLR4 signaling that become diminished during NEC pathogenesis and focused on the intracellular stress response protein and chaperone heat shock protein-70 (Hsp70). We demonstrate that the induction of intracellular Hsp70 in enterocytes dramatically reduced TLR4 signaling, as assessed by LPS-induced NF-κB translocation, cytokine expression, and apoptosis. These findings were confirmed in vivo, using mice that either globally lacked Hsp70 or overexpressed Hsp70 within the intestinal epithelium. TLR4 activation itself significantly increased Hsp70 expression in enterocytes, which provided a mechanism of autoinhibition of TLR4 signaling in enterocytes. In seeking to define the mechanisms involved, intracellular Hsp70-mediated inhibition of TLR4 signaling required both its substrate-binding EEVD domain and association with the cochaperone CHIP, resulting in ubiquitination and proteasomal degradation of TLR4. The expression of Hsp70 in the intestinal epithelium was significantly decreased in murine and human NEC compared with healthy controls, suggesting that loss of Hsp70 protection from TLR4 could lead to NEC. In support of this, intestinal Hsp70 overexpression in mice and pharmacologic upregulation of Hsp70 reversed TLR4-induced cytokines and enterocyte apoptosis, as well as prevented and treated experimental NEC. Thus, a novel TLR4 regulatory pathway exists within the newborn gut involving Hsp70 that may be pharmacologically activated to limit NEC severity.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Enterocolitis, Necrotizing / immunology
  • Enterocolitis, Necrotizing / metabolism
  • Enterocolitis, Necrotizing / pathology
  • Female
  • HSP70 Heat-Shock Proteins / immunology*
  • HSP70 Heat-Shock Proteins / metabolism
  • Humans
  • Infant, Newborn
  • Intestinal Mucosa / immunology*
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Lipopolysaccharides / pharmacology
  • Male
  • Mice
  • NF-kappa B / immunology
  • NF-kappa B / metabolism
  • Proteasome Endopeptidase Complex / immunology
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Structure, Tertiary
  • Proteolysis / drug effects
  • Signal Transduction / drug effects
  • Signal Transduction / immunology*
  • Toll-Like Receptor 4 / immunology*
  • Toll-Like Receptor 4 / metabolism
  • Ubiquitin-Protein Ligases / immunology
  • Ubiquitin-Protein Ligases / metabolism
  • Ubiquitination / drug effects
  • Ubiquitination / immunology

Substances

  • HSP70 Heat-Shock Proteins
  • Lipopolysaccharides
  • NF-kappa B
  • TLR4 protein, human
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • STUB1 protein, human
  • Stub1 protein, mouse
  • Ubiquitin-Protein Ligases
  • Proteasome Endopeptidase Complex